Freestone Jack, Mooney-Somers Julie, Hudson Suzie
Alcohol and Other Drug Research and Development, ACON, Sydney, Australia.
Sydney Health Ethics, School of Public Health, University of Sydney, Sydney, Australia.
Drug Alcohol Rev. 2022 Jan;41(1):39-42. doi: 10.1111/dar.13367. Epub 2021 Aug 9.
Sexuality and gender diverse Australians are a priority population in federal and state-based alcohol and other drug (AOD) strategies. Research evidence shows higher prevalence of AOD use by lesbian, gay, bisexual, transgender and queer (LGBTQ) people, riskier use and a higher proportion have accessed AOD treatment. Despite these disparities, Australian AOD treatment services do not routinely collect data on sexuality or gender identity. As a result, the treatment needs, experiences and outcomes of LGBTQ people remain largely invisible. The Australian Bureau of Statistics' recently released standardised indicators for the recording of sex, gender, variations of sex characteristics and sexual orientation presents an opportunity for the AOD sector to implement inclusive data collection as a foundational step towards achieving policy priorities for LGBTQ people. This commentary includes an implementation case study from the New South Wales non-government AOD treatment sector, where sexuality and gender identity indicators have been collected since 2016.
性取向和性别多样化的澳大利亚人是联邦和州级酒精及其他药物(AOD)战略中的重点人群。研究证据表明,女同性恋、男同性恋、双性恋、跨性别者和酷儿(LGBTQ)人群中使用AOD的比例更高,使用风险更大,且有更高比例的人接受过AOD治疗。尽管存在这些差异,但澳大利亚的AOD治疗服务机构通常不收集有关性取向或性别认同的数据。因此,LGBTQ人群的治疗需求、经历和治疗结果在很大程度上仍然不为人知。澳大利亚统计局最近发布的关于记录性别、性特征变异和性取向的标准化指标,为AOD部门提供了一个机会,可将包容性数据收集作为实现LGBTQ人群政策优先事项的基础步骤加以实施。本评论包括新南威尔士州非政府AOD治疗部门的一个实施案例研究,该部门自2016年以来一直在收集性取向和性别认同指标。